Dangerous snoring may affect one in five people without them knowing

Written By :  Isra Zaman
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-05-15 03:45 GMT   |   Update On 2023-05-15 08:46 GMT

Around one in five people may be suffering with obstructive sleep apnoea (OSA), according to a study published in the ERJ Open Research. People with OSA often snore loudly, their breathing starts and stops during the night, and they may wake up several times. Not only does this cause tiredness, but it can also increase the risk of high blood pressure, stroke, heart disease and type 2 diabetes.

Treatments and lifestyle changes can help people with OSA. However, the new study also suggests that only a small proportion of people with symptoms of OSA have been diagnosed and are receiving help for the condition.

The study included data on 20,151 French adults. Researchers recorded how many participants had been diagnosed with OSA. They also used a questionnaire to gauge how many participants might have undiagnosed OSA. Researchers then used this data to calculate the proportion of the French population who are likely to be affected by OSA. They found that around one in five (20.2%) were highly likely to have OSA while only 3.5% were being treated for the condition.

Advertisement

OSA was more common in men in people who were older, had cardiovascular disease, lower socioeconomic status or were less physically active, in smokers and in people with symptoms of depression. Women were at a higher risk of going undiagnosed with OSA.

Reference:

Prevalence, treatment and determinants of obstructive sleep apnoea and its symptoms in a population-based French cohort,ERJ Open Research

DOI 10.1183/23120541.00053-2023

Full View
Tags:    
Article Source : ERJ Open Research

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News